Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fluocinonide
Drug ID BADD_D00925
Description A topical glucocorticoid used in the treatment of eczema.
Indications and Usage A topical anti-inflammatory product for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Marketing Status Prescription; Discontinued
ATC Code C05AA11; D07AC08
DrugBank ID DB01047
KEGG ID D00325
MeSH ID D005447
PubChem ID 9642
TTD Drug ID D03ZZK
NDC Product Code 63629-2508; 0093-0262; 70771-1393; 62991-2865; 68682-992; 45802-151; 68462-505; 43386-026; 70771-1375; 71085-004; 70710-1284; 72578-087; 68071-4619; 53002-9201; 0093-0264; 51552-0056; 68071-2202; 63629-2337; 68071-2200; 16714-502; 50090-1671; 71428-001; 0168-0134; 47781-569; 43386-095; 53002-9200; 0093-0263; 47781-602; 68788-8105; 50090-2419; 50090-3277; 71085-005; 70700-146; 63629-2339; 46439-8707; 68071-4921; 63629-2510; 51672-1254; 68071-2541; 66267-973; 69238-1534; 0713-0664; 68071-1654; 52128-176; 68788-7541; 68071-4732; 68071-2667; 49452-3161; 40032-026; 59088-755; 52565-025; 40032-095; 0713-0803; 50090-1784; 68788-7706; 51672-1386; 51672-1253; 51672-1264; 33342-320; 71205-092; 52565-079; 50090-2982; 51672-1279; 68071-1754; 0168-0135; 51672-1353; 52565-040; 51672-1273; 63629-2509; 53002-9202; 63187-033; 71085-006; 69238-1271; 52565-054; 51862-494; 0472-0829; 68071-4219; 99207-525; 0168-0457; 63629-2338
Synonyms Fluocinonide | Fluocinolone Acetonide 21-Acetate | Acetonide 21-Acetate, Fluocinolone | Fluocinolone Acetonide 21 Acetate | Fluocinonide FAPG | FAPG, Fluocinonide | Fluocinolide | Lidex | Lidemol | Lyderm | Tiamol | Topsyne | Novoter | Topsym | Topsyn | Klariderm | Metosyn
Chemical Information
Molecular Formula C26H32F2O7
CAS Registry Number 356-12-7
SMILES CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Skin atrophy23.01.05.001--
Skin disorder23.03.03.007--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Swelling08.01.03.015--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Tongue discolouration07.14.02.006--Not Available
Skin tightness23.03.03.018--Not Available
Application site burn23.03.11.013; 12.07.01.038; 08.02.01.038--Not Available
The 2th Page    First    Pre   2    Total 2 Pages